For instance, transforming growth factor-β (TGF-β) can promote a pro-tumor N2 phenotype, whereas interferon-β (IFN-β) or the inhibition of TGF-β induce an anti-tumor N1 phenotype [37,44]. The gene discussed is TGFB1; the disease is neoplasm.